BRIAN J. WALKER
Manager, Controls and Grid-Edge Decarbonization
Also affiliated: University College Dublin (2004); Queen's University Belfast (1970–2022); Indiana University Health (2021); Belfast Health and Social Care Trust (2010); Monsanto (United States) (1999); Dalhousie University (1991); Royal Marsden NHS Foundation Trust (2016); United States Department of Energy (2019–2022); Defence Science and Technology Laboratory (2009); Royal College of Surgeons in Ireland (1998–2000); University of Miami (2025); University of Alberta (1992); National University of Ireland, Maynooth (1993); University of California, Los Angeles (2019); Universität Innsbruck (2008); Brookhaven National Laboratory (1985); SUNY Upstate Medical University (2025); Cornell University (2005); University of Cambridge (2012–2015); Musgrave Park Hospital (1994); Department of Education (1994); Sylvester Comprehensive Cancer Center (2025); Indiana University Melvin and Bren Simon Comprehensive Cancer Center (2021); Massachusetts Institute of Technology (2009–2012); Rice University (1978); Friedrich Miescher Institute (1985–1988)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Brian J. Walker's research has explored diverse areas including singlet exciton fission in solution, the role of linolenic acid in rat development, and proteasome inhibitors in cancer therapy. His work has also investigated resonant energy transfer from pentacene to PbSe nanocrystals, the formation of CdSe/CdS core/shell quantum dots, and mechanistic insights into the formation of InP quantum dots. He has also contributed to the understanding of the Baylis-Hillman mechanism.
Walker leads a research group and has a significant publication record, with 485 total publications and 7,794 citations, resulting in an h-index of 43. He is recognized as a highly cited researcher. His collaborations include work with Melinda J. McAfee, J. L. Pack, Peter Szwedo, and Karie Sanford, all from the University of Arkansas at Little Rock, with whom he shares one publication each.
Metrics
- h-index: 43
- Publications: 467
- Citations: 7,845
Positions
-
Program Manager, Emerging Building Technologies 2016–presentU.S. Department of Energy Critical Minerals and Energy Innovation ORCID
-
Manager, Controls and Grid-Edge Decarbonization publications 2023–2025University of Arkansas at Little Rock Listing
Selected Publications
-
Solvent-Free and Microwave-Assisted Synthesis Enables Formation of Imidazole and Pyrazole Derivatives Through Epoxide Ring Opening (2025)
-
Dehydrogenative Conversions of Aldehydes and Amines to Amides Catalyzed by a Nickel(II) Pincer Complex (2023)
-
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death (2019)
Collaboration Network
Top Collaborators
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Similar Researchers
Based on overlapping research topics